On this page
BATES ERNEST A
Insider
First SEC filing: Nov. 20, 2019 · Latest: Nov. 20, 2019
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Jan. 20, 2022 | ASTH | A | 8,500 | · | · | 8,500 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 11, 2020 | ASTH | A | 20,000 | · | · | 20,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Oct. 11, 2019 | ASTH | A | 11,000 | · | · | 18,500 Direct | +146.67% | Acquired | (price as of 2026-10-02) |
| Jan. 11, 2019 | ASTH | A | 7,500 | · | · | 7,500 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 11, 2019 | ASTH | A | 7,500 | · | · | 7,500 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 20, 2022 | ASTH | Stock Option (right to buy) | Common Stock | $53.01 | Jan. 18, 2025 | 8,500 | Acquired |
| Nov. 11, 2020 | ASTH | Stock Option (right to buy) | Common Stock | $18.20 | Nov. 11, 2025 | 20,000 | Acquired |
| Oct. 11, 2019 | ASTH | Stock Options | Common Stock | $15.35 | Oct. 11, 2024 | 11,000 | Acquired |
| Jan. 11, 2019 | ASTH | Stock Options | Common Stock | $18.11 | Jan. 11, 2024 | 7,500 | Acquired |
| Jan. 11, 2019 | ASTH | Options | Common Stock | $18.11 | Dec. 31, 2023 | 7,500 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).